eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of…
Biotechnology
US, Solana Beach [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
eFFECTOR Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
eFFECTOR Therapeutics, Inc. has no acquisition track records yet.